Back
ProShares Short Real Estate Vs. Nutex Health Industry Stock Comparison
Buy
53
REK
ProShares Short Real Estate
Last Price:
16.64
Seasonality Move:
-4.57%
Buy
78
NUTX
Nutex Health
Last Price:
32.61
Seasonality Move:
-16.36%
Buy
53
ProShares Short Real Estate (REK)
is a Buy
Is ProShares Short Real Estate a Buy, Sell or Hold?
- The current ProShares Short Real Estate [REK] share price is $16.83. The Score for REK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- REK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Nutex Health (NUTX)
is a Buy
Is Nutex Health a Buy, Sell or Hold?
- The current Nutex Health [NUTX] share price is $37.56. The Score for NUTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- NUTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REK Stock Price Chart
What is ProShares Short Real Estate's stock price today?
-
The ProShares Short Real Estate share price today is $16.83
The current trend is relatively stagnant and REK is experiencing slight buying pressure.
NUTX Stock Price Chart
What is Nutex Health's stock price today?
-
The Nutex Health share price today is $37.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUTX is experiencing selling pressure, which indicates risk of future bearish movement.
REK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 55.58 | Buy |
| Chaikin Money Flow: | 6666 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NUTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.63 | Buy |
| Relative Strength Index (14 RSI): | 74.06 | Buy |
| Chaikin Money Flow: | 232476 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
REK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.73 | Buy |
| 20-day SMA: | 16.51 | Buy |
| 50-day SMA: | 16.46 | Buy |
| 200-day SMA: | 18.25 | Sell |
| 8-day EMA: | 16.68 | Buy |
| 20-day EMA: | 16.59 | Buy |
| 50-day EMA: | 16.68 | Buy |
| 200-day EMA: | 17.95 | Sell |
NUTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.89 | Buy |
| 20-day SMA: | 25.02 | Buy |
| 50-day SMA: | 22.95 | Buy |
| 200-day SMA: | 13.95 | Buy |
| 8-day EMA: | 29.19 | Buy |
| 20-day EMA: | 25.9 | Buy |
| 50-day EMA: | 22.5 | Buy |
| 200-day EMA: | 24.44 | Buy |
ProShares Short Real Estate Earnings Growth & REK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nutex Health Earnings Growth & NUTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $1.74 per share.
ProShares Short Real Estate Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nutex Health Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||